JMPWA
AVDL

JP Morgan Private Wealth Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-500,000
Closed -$8.24M – 1717
2023
Q2 		$8.24M Buy
+500,000
New +$6.5M 0.04% 256
2021
Q1 		– Sell
-10,000
Closed -$67K – 1746
2020
Q4 		$67K Buy
+10,000
New +$62.5K ﹤0.01% 1688

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

JP Morgan Private Wealth Advisors's AVDL Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors sold out of Avadel Pharmaceuticals (AVDL) in Q3 2023, closing a stake of 500,000 shares — an estimated $8.24M sold.

JP Morgan Private Wealth Advisors first reported a position in AVDL in Q4 2020 and held it in 2 quarters. The position peaked at $8.24M in Q2 2023. 99 funds tracked by Wall St. Rank hold AVDL as of Q3 2023.

  • JP Morgan Private Wealth Advisors reported no remaining Avadel Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 500,000 Avadel Pharmaceuticals shares in Q3 2023, an estimated $8.24M.
  • JP Morgan Private Wealth Advisors first reported a position in Avadel Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's Avadel Pharmaceuticals position peaked at $8.24M in Q2 2023.
  • 99 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.